RSSDI Repository, Complications of Diabetes Demonstration RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

  • Home/
  • Article /
  • Pre-therapeutic Biomarkers for Ranibizumab Therapy among Type 2 Diabetic Patients with Diabetic Macular Edema.

Pre-therapeutic Biomarkers for Ranibizumab Therapy among Type 2 Diabetic Patients with Diabetic Macular Edema.

Add to Collection
2021 Jan 1 Others SK Paine, CK Bhattacharjee, G Bhaduri… - Optometry and Vision …, 2021 - journals.lww.com

Full Author : ['Paine, Suman K', 'Bhattacharjee, Chandra K', 'Bhaduri, Gautam', 'Pramanik, Subhasish', 'Borah, Prasanta K', 'Mahanta, Jagadish', 'Basu, Analabha', 'Mondal, Lakshmi K']
Journal Title : Optometry and vision science : official publication of the American Academy of Optometry
Chapter : Section3
Journal Year : 2021

SIGNIFICANCE: A differential outcome in randomized controlled trials of anti-vascular endothelial growth factor (anti-VEGF) therapy, including ranibizumab, for diabetic macular edema is a major dilemma for planning, optimizing, and managing clinical usage..... Read More

Keywords : ["ranibizumab therapy among type diabetic patient", "diabetic macular edema", "pretherapeutic biomarker"]
PubMed Link : https://journals.lww.com/optvissci/Fulltext/2021/01000/Pre_therapeutic_Biomarkers_for_Ranibizumab_Therapy.12.aspx